Delivery Order SPE2DR25D3111-SPE2DR26FF3SA
- Not listed
- The Defense Logistics Agency awarded a $1,323.98 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ml 3ml insulin pens. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,278.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,222.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. The award was made on December 1, 2025, with an ultimate completion date of December 2, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, valued at $1,312.94. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across...
- The Defense Logistics Agency awarded a $1,350.99 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of September 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 17, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin injection pens on November 3, 2025, with a contract ceiling value of $3,565.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,201.44 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL) on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a ceiling value of $1,397.48. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to complete by May 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency (DLA) awarded a $1,188.00 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens under a firm fixed-price contract type. The award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3SADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, valued at $1,095.17. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), was competitively awarded with no set-aside designation and is scheduled for completion by December 19, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's established role as a critical pharmaceutical vendor for federal military and veteran healthcare systems. As a major pharmaceutical distributor headquartered in Conshohocken, the company holds a $999.999 billion umbrella contract with DLA Troop Support Medical through December 2026, which serves as the vehicle for this and numerous other delivery orders across multiple therapeutic domains. The award of diabetes management medications such as Lantus demonstrates the company's continued participation in supplying specialized pharmaceutical products to support Defense Health Agency operations and broader military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/17/25 |